Famotidine, a New, Potent, Long-Acting Histamine H2-Receptor Antagonist: Comparison With Cimetidine and Ranitidine in the Treatment of Zollinger-Ellison Syndrome

This publication has 20 references indexed in Scilit:

• Basis for failure of cimetidine in patients with Zollinger-Ellison syndrome
  Digestive Diseases and Sciences, 1984
• DURATION OF ACTION OF NEW H2-BLOCKERS
  The Lancet, 1984
• Comparison of Ranitidine and Cimetidine in the Treatment of Gastric Hypersecretion
  Annals of Internal Medicine, 1983
• Diagnosis and Management of the Zollinger-Ellison Syndrome
  Journal of Clinical Gastroenterology, 1983
• 24 HOUR INTRAGASTRIC ACIDITY AND SINGLE NIGHT-TIME DOSE OF THREE H2-BLOCKERS
  The Lancet, 1983
• Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs
  European Journal of Pharmacology, 1983
• Specific binding of 3H-tiotidine to histamine H2 receptors in guinea pig cerebral cortex
  Nature, 1983
• Effect of a new potent H2-receptor antagonist 3[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric mucosal histamine-sensitive adenylate cyclase from guinea pig
  Biochemical Pharmacology, 1983
• Effect of isopropamide on response to oral cimetidine in patients with Zollinger-Ellison syndrome
  Digestive Diseases and Sciences, 1982
• H₂-Histamine Receptor Blocking Agents in the Zollinger-Ellison Syndrome
  Annals of Internal Medicine, 1977